Home
New Enterprise Associates 16 reported a 12% stake in Trevi Therapeutics TRVI · 15,074,080 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 12%
- Last report
- 15% · filed 25/03/20
- Shares held
- 15,074,080 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 25/08/07
- Filed
- 25/08/11
12% stake · −3.0pp from the last report
- Stake
- 12%
- Last report
- 15%
- Since last report
- −3.0pp
Trevi Therapeutics trades, last 26 weeks
What else happened in Trevi Therapeutics around then
Filed or reported within 30 days of the trade day · 25/07/08~25/09/06New Enterprise Associates 16's other 5% stake reports
- New Enterprise Associates 16
5% stakeTrevi Therapeutics
5% stakeTrevi Therapeutics
TRVI
10.5% stake
15,074,080 sh
10.5% stake
Filed 05/07
- New Enterprise Associates 16
5% stakeTrevi Therapeutics
5% stakeTrevi Therapeutics
TRVI
11.6% stake
15,074,080 sh
11.6% stake
Filed 02/13
- New Enterprise Associates 16
5% stakeMarker Therapeutics
5% stakeMarker Therapeutics
MRKR
9.9% stake
1,670,081 sh
9.9% stake
Filed 25/11/17
- New Enterprise Associates 16
5% stakeMarker Therapeutics
5% stakeMarker Therapeutics
MRKR
12.6% stake
1,625,678 sh
12.6% stake
Filed 25/08/18
- New Enterprise Associates 16
5% stakeTrevi Therapeutics
5% stakeTrevi Therapeutics
TRVI
15% stake
15,074,080 sh
15% stake
Filed 25/03/20
